These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1849042)

  • 21. A high performance liquid chromatography method for vinorelbine and 4-O-deacetyl vinorelbine: a decade of routine analysis in human blood.
    Puozzo C; Ung HL; Zorza G
    J Pharm Biomed Anal; 2007 May; 44(1):144-9. PubMed ID: 17306947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice.
    Cummings J; Double JA; Bibby MC; Farmer P; Evans S; Kerr DJ; Kaye SB; Smyth JF
    Cancer Res; 1989 Jul; 49(13):3587-93. PubMed ID: 2731178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).
    Rahmani R; Martin M; Barbet J; Cano JP
    Cancer Res; 1984 Dec; 44(12 Pt 1):5609-13. PubMed ID: 6498821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism pathway of vinorelbine (Navelbine) in human: characterisation of the metabolites by HPLC-MS/MS.
    de Graeve J; van Heugen JC; Zorza G; Fahy J; Puozzo C
    J Pharm Biomed Anal; 2008 May; 47(1):47-58. PubMed ID: 18242035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
    Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K
    Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).
    Arteaga CL; Brown TD; Kuhn JG; Shen HS; O'Rourke TJ; Beougher K; Brentzel HJ; Von Hoff DD; Weiss GR
    Cancer Res; 1989 Aug; 49(16):4648-53. PubMed ID: 2743343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
    Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
    Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
    Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer.
    Reece PA; Morris RG; Bishop JF; Olver IN; Raghavan D
    Cancer Res; 1987 Jun; 47(11):2996-9. PubMed ID: 2952262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of 4-acetyl tritium vinblastine in two patients.
    Owellen RJ; Hartke CA
    Cancer Res; 1975 Apr; 35(4):975-80. PubMed ID: 1116154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of navelbine after oral administration in the dog and the monkey.
    Zhou XJ; Landi H; Breillout F; Rahmani R
    Anticancer Drugs; 1993 Aug; 4(4):511-5. PubMed ID: 8400355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report.
    Vokes EE; Rosenberg R; Jahanzeb M; Craig J; Gralla R; Belani C; Jones S; Bigley J; Hohneker J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):35-8; discussion 38-41. PubMed ID: 7973767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical pharmacokinetics of navelbine after oral administration, in vitro metabolism and interindividual variability].
    Sahnoun Z; Zhou XJ; Bore P; Monjanel S; Favre R; Durand A; Rahmani R
    Bull Cancer; 1990; 77(11):1115-21. PubMed ID: 2275987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human hepatic uptake of two vinca alkaloids: navelbine and vincristine.
    Rahmani-Jourdheuil D; Coloma F; Placidi M; Rahmani R
    J Pharm Sci; 1994 Apr; 83(4):468-71. PubMed ID: 8046598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
    Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
    Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I pharmacologic study of a new Vinca alkaloid: navelbine.
    Mathé G; Reizenstein P
    Cancer Lett; 1985 Jul; 27(3):285-93. PubMed ID: 4016723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography.
    van Tellingen O; Sonneveldt AL; Beijnen JH; Nooijen WJ; Kettenes-van den Bosch JJ; Versluis C; Bult A
    Cancer Chemother Pharmacol; 1994; 33(5):425-34. PubMed ID: 8306418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.